TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33007442

Group type: EXPERIMENTAL
Intervention: PCplanner intervention
Number of subjects: 2000000

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 2000000
Study: 34564938

Group type: EXPERIMENTAL
Intervention: Rosuvastatin 20 mg once daily for 180 days
Number of subjects: 312

Group type: COMPARATOR
Intervention: No rosuvastatin for 6 months (Control)
Number of subjects: 312
Study: 36268690

Group type: EXPERIMENTAL
Intervention: HFHD+HDF
Number of subjects: 0

Group type: COMPARATOR
Intervention: LFHD+HDF
Number of subjects: 0
Study: 33346320

Group type: EXPERIMENTAL
Intervention: Probiotics
Number of subjects: 20
Study: 32029509

Group type: EXPERIMENTAL
Intervention: Bortezomib 1.3 mg/m2 administered on days 1, 4, and 8 of each chemotherapy course.
Number of subjects: 1097

Group type: EXPERIMENTAL
Intervention: Bortezomib with standard chemotherapy.
Number of subjects: 1097

Group type: COMPARATOR
Intervention: Standard chemotherapy without bortezomib.
Number of subjects: 1097
Study: 35654120

Group type: EXPERIMENTAL
Intervention: Coupled inhibitory‐facilitatory rTMS (1 Hz over contralesional M1 and 10 Hz over ipsilesional M1)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Contralesional sham stimulation and ipsilesional 10 Hz stimulation
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Contralesional 1 Hz rTMS and ipsilesional sham stimulation
Number of subjects: 63

Group type: COMPARATOR
Intervention: Bilateral sham stimulation only
Number of subjects: 63
Study: 34762781

Group type: EXPERIMENTAL
Intervention: Radiofrequency ablation
Number of subjects: 10

Group type: COMPARATOR
Intervention: Thyroidectomy
Number of subjects: 10
Study: 32557843

Group type: EXPERIMENTAL
Intervention: Seeking Safety (SS)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Concurrent Treatment of PTSD and Substance Use Disorders Using Prolonged Exposure (COPE)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Posttreatment PTSD diagnosis
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Posttreatment AUD diagnosis
Number of subjects: 73
Study: 35738685

Group type: EXPERIMENTAL
Intervention: Positive imagery condition
Number of subjects: 44

Group type: COMPARATOR
Intervention: Neutral imagery condition
Number of subjects: 44
Study: 32725589

Group type: EXPERIMENTAL
Intervention: Customized embryo transfer (cET, n = 157 patients)
Number of subjects: 217

Group type: COMPARATOR
Intervention: Control group (classical procedure, n = 60)
Number of subjects: 217
Study: 35544456

Group type: EXPERIMENTAL
Intervention: Brief befriending meditation
Number of subjects: 922

Group type: COMPARATOR
Intervention: Attentional control condition
Number of subjects: 922
Study: 32318834

Group type: EXPERIMENTAL
Intervention: Endoscopic transpapillary stent placement (ETSP)
Number of subjects: 12
Study: 33739059

Group type: EXPERIMENTAL
Intervention: Non-Pharmacological Techniques (NPT) in addition to standard pharmacological techniques
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard pharmacological techniques
Number of subjects: 50
Study: 33020094

Group type: EXPERIMENTAL
Intervention: Cognitive behavioural therapy combined with medication (CBT+M)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Medication-only group (M)
Number of subjects: 0
Study: 34365030

Group type: EXPERIMENTAL
Intervention: Nurse Home Visiting (NHV)
Number of subjects: 722

Group type: COMPARATOR
Intervention: Control: Universal well-child nursing service
Number of subjects: 722
Study: 33172941

Group type: EXPERIMENTAL
Intervention: Intravenous desmopressin 20 μg in 50 mL sodium chloride 0.9% infused over 20 min
Number of subjects: 50

Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Intravenous desmopressin
Number of subjects: 50
Study: 35838997

Group type: EXPERIMENTAL
Intervention: CDM group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 34321539

Group type: EXPERIMENTAL
Intervention: Denneroll cervical traction
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 80
Study: 32217783

Group type: EXPERIMENTAL
Intervention: Energy conservation technique (ECT)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control condition (climbing stairs at own pace)
Number of subjects: 22
Study: 35262556

Group type: EXPERIMENTAL
Intervention: Tooth bleaching treatment
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: OHIP‐Aes‐Braz
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Correlation with tooth color satisfaction and self‐perceived oral health
Number of subjects: 79
Study: 33074282

Group type: EXPERIMENTAL
Intervention: Higher-calorie refeeding, beginning at 2000 kcal/d and increasing by 200 kcal/d
Number of subjects: 120

Group type: COMPARATOR
Intervention: Lower-calorie refeeding, beginning at 1400 kcal and increasing by 200 kcal every other day
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Higher-calorie refeeding
Number of subjects: 120
Study: 33106874

Group type: EXPERIMENTAL
Intervention: Order recommender system
Number of subjects: 43
Study: 35864625

Group type: EXPERIMENTAL
Intervention: Tranexamic Acid (TXA) - 25 mg/kg bolus followed by 1 mg/kg/hour infusion
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo (saline infusion)
Number of subjects: 50
Study: 35003484

Group type: EXPERIMENTAL
Intervention: Opalescence Boost only
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Opalescence Boost plus Er:YAG laser
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Opalescence Boost plus Nd:YAG laser
Number of subjects: 68

Group type: COMPARATOR
Intervention: Control
Number of subjects: 68
Study: 36263691

Group type: EXPERIMENTAL
Intervention: Agomelatine therapy (AT) with cognitive behavior therapy (CBT)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Agomelatine therapy (AT) without cognitive behavior therapy (CBT)
Number of subjects: 60
Study: 34301748

Group type: EXPERIMENTAL
Intervention: osimertinib
Number of subjects: 682

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 682
Study: 32516270

Group type: EXPERIMENTAL
Intervention: Baseline smoking
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Baseline drinking
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Baseline alcohol craving
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Baseline tobacco craving
Number of subjects: 34
Study: 33812977

Group type: EXPERIMENTAL
Intervention: Amisulpride
Number of subjects: 5866

Group type: EXPERIMENTAL
Intervention: Quetiapine
Number of subjects: 5866

Group type: EXPERIMENTAL
Intervention: Lurasidone
Number of subjects: 5866

Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 5866

Group type: EXPERIMENTAL
Intervention: Perphenazine
Number of subjects: 5866

Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 5866

Group type: EXPERIMENTAL
Intervention: Sertindole
Number of subjects: 5866

Group type: EXPERIMENTAL
Intervention: Ziprasidone
Number of subjects: 5866

Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 5866

Group type: COMPARATOR
Intervention: Clozapine
Number of subjects: 5866
Study: 33198760

Group type: EXPERIMENTAL
Intervention: PM2.5 exposure (mean: 37.8 μg/m3, SD 6.5)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Filtered air (mean: 2.1 μg/m3, SD 2.6)
Number of subjects: 20
Study: 33190607

Group type: EXPERIMENTAL
Intervention: Abdominal drawing-in maneuver (ADIM) technique for 1 minute, repeated three times during 41 minutes of sitting.
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control condition (sitting without ADIM technique).
Number of subjects: 24
Study: 32096346

Group type: EXPERIMENTAL
Intervention: Nomogram for overall survival (OS)
Number of subjects: 509

Group type: EXPERIMENTAL
Intervention: Nomogram for recurrence-free survival (RFS)
Number of subjects: 509

Group type: EXPERIMENTAL
Intervention: Calibration curves
Number of subjects: 509

Group type: EXPERIMENTAL
Intervention: Kaplan-Meier curves and Decision Curve Analysis (DCA)
Number of subjects: 509
Study: 35473570

Group type: EXPERIMENTAL
Intervention: Mobile Subthreshold Exercise Program (MSTEP)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Stretching condition (control)
Number of subjects: 200
Study: 34304826

Group type: EXPERIMENTAL
Intervention: High-intensity interval training (HIIT) for 6 months, 30 min, 3 times per week, 10-30 s bouts at >90% age-predicted maximum heart rate with equal rest
Number of subjects: 616

Group type: COMPARATOR
Intervention: Control group (not specified intervention)
Number of subjects: 616
Study: 32199333

Group type: EXPERIMENTAL
Intervention: Pre‐term born adults
Number of subjects: 37

Group type: COMPARATOR
Intervention: Full‐term born controls
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Both groups (normoxia and hypoxia)
Number of subjects: 37
Study: 35583606

Group type: EXPERIMENTAL
Intervention: Cold events (temperature below freezing)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Warm events (minimum temperature > 10 °C)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cold waves
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Heat waves
Number of subjects: 0
Study: 34689453

Group type: EXPERIMENTAL
Intervention: Complete cervical third protection with gingival dam
Number of subjects: 35

Group type: COMPARATOR
Intervention: Traditional gingival barrier application
Number of subjects: 35
Study: 34552200

Group type: EXPERIMENTAL
Intervention: 800 mg DHA/day
Number of subjects: 300

Group type: COMPARATOR
Intervention: 200 mg DHA/day
Number of subjects: 300
Study: 32570710

Group type: EXPERIMENTAL
Intervention: Sugarcane flour (3 g per day)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Cellulose placebo (3 g per day)
Number of subjects: 43
Study: 35556174

Group type: EXPERIMENTAL
Intervention: Flowable bulk-fill and nanoparticulate composite resins (ABF)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Flowable bulk-fill and microhybrid composite resins (XST)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Conventional microhybrid composite resin (PA)
Number of subjects: 53
Study: 35096107

Group type: EXPERIMENTAL
Intervention: Qinpi Tongfeng Formula (QPTFF) combined with bloodletting therapy
Number of subjects: 86

Group type: COMPARATOR
Intervention: Colchicine tablets
Number of subjects: 86
Study: 32663912

Group type: EXPERIMENTAL
Intervention: mRNA-1273 25 μg
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: mRNA-1273 100 μg
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: mRNA-1273 250 μg
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: mRNA-1273
Number of subjects: 45
Study: 616775744

Group type: EXPERIMENTAL
Intervention: Pharmaco-invasive (PI)
Number of subjects: 143

Group type: COMPARATOR
Intervention: Primary PCI (PPCI)
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: Both PI and PPCI
Number of subjects: 143
Study: 34560797

Group type: EXPERIMENTAL
Intervention: MAKS intervention (Motor, Activities of daily living, Cognitive and Social-communicative component) implemented in DCC
Number of subjects: 287

Group type: COMPARATOR
Intervention: No MAKS intervention in DCC
Number of subjects: 287
Study: 34622665

Group type: EXPERIMENTAL
Intervention: Vorapaxar
Number of subjects: 5845

Group type: EXPERIMENTAL
Intervention: Statin therapy
Number of subjects: 5845

Group type: EXPERIMENTAL
Intervention: Combination of statin therapy and vorapaxar
Number of subjects: 5845
Study: 32814661

Group type: COMPARATOR
Intervention: 5 mg/ml fibrinogen and 25 U/ml thrombin (physiological as a control)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 40 mg/ml fibrinogen and 250 U/ml thrombin (low adhesive)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 80 mg/ml fibrinogen and 250 U/ml thrombin (high adhesive)
Number of subjects: 48
Study: 35387238

Group type: EXPERIMENTAL
Intervention: Sildenafil 25 mg twice a day before chemotherapy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 32798159

Group type: EXPERIMENTAL
Intervention: Erich arch bars (EABs)
Number of subjects: 15
Study: 35396305

Group type: EXPERIMENTAL
Intervention: PTI (Intervention for patients)
Number of subjects: 2334

Group type: COMPARATOR
Intervention: UC (Usual Care)
Number of subjects: 2334

Group type: EXPERIMENTAL
Intervention: PFI (Intervention for primary care professionals)
Number of subjects: 2334

Group type: EXPERIMENTAL
Intervention: CBI (Combined intervention for patients and professionals)
Number of subjects: 2334
Study: 33965944

Group type: EXPERIMENTAL
Intervention: Endobronchial coil treatment
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control (Standard-of-Care Medical Management)
Number of subjects: 120
Study: 35708691

Group type: EXPERIMENTAL
Intervention: Intervention 1 (screening mammogram result letter with breast density messaging and existing density information letter)
Number of subjects: 1420

Group type: EXPERIMENTAL
Intervention: Intervention 2 (screening mammogram result letter with breast density messaging and health literacy-sensitive version)
Number of subjects: 1420

Group type: COMPARATOR
Intervention: Control (screening mammogram result letter without breast density messaging)
Number of subjects: 1420
Study: 33549554

Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10 mg daily
Number of subjects: 4744

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4744
Study: 34715162

Group type: EXPERIMENTAL
Intervention: piTBS
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: HF-rTMS
Number of subjects: 75

Group type: COMPARATOR
Intervention: sham
Number of subjects: 75
Study: 34666678

Group type: EXPERIMENTAL
Intervention: Optimisation intervention for personal continuity of care
Number of subjects: 0
Study: 35123203

Group type: EXPERIMENTAL
Intervention: Online multi-domain cognitive training (CT), 24 sessions over 8 weeks
Number of subjects: 71

Group type: COMPARATOR
Intervention: Active control condition
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Online multi-domain cognitive training (CT)
Number of subjects: 71
Study: 32882244

Group type: EXPERIMENTAL
Intervention: Balanced crystalloids (lactated Ringer's solution or Plasma‐Lyte A)
Number of subjects: 1641

Group type: COMPARATOR
Intervention: Saline (0.9% sodium chloride)
Number of subjects: 1641
Study: 35109526

Group type: EXPERIMENTAL
Intervention: Doll therapy (DT)
Number of subjects: 129

Group type: COMPARATOR
Intervention: Active control (cube)
Number of subjects: 129
Study: 32194222

Group type: EXPERIMENTAL
Intervention: n-3 PUFAs (2,700 mg/day)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (900 mg of edible paraffin)
Number of subjects: 60
Study: 36042488

Group type: EXPERIMENTAL
Intervention: 4% tetrasodium EDTA (KiteLock Sterile Locking Solution™)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard of care (normal saline as a catheter locking solution)
Number of subjects: 0
Study: 34938828

Group type: EXPERIMENTAL
Intervention: Computer delivered brief alcohol intervention (CBI)
Number of subjects: 439

Group type: EXPERIMENTAL
Intervention: Computer delivered brief alcohol intervention with interactive voice response counseling and text messages (CBI‐IVR‐TM)
Number of subjects: 439

Group type: COMPARATOR
Intervention: Attention control
Number of subjects: 439

Group type: EXPERIMENTAL
Intervention: All groups (CBI, CBI‐IVR‐TM, Attention control)
Number of subjects: 439
Study: 33891333

Group type: EXPERIMENTAL
Intervention: HTL0009936 (IV)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Physostigmine
Number of subjects: 0
Study: 32353277

Group type: EXPERIMENTAL
Intervention: Multisystemic therapy (3-5 months) followed by management as usual
Number of subjects: 684

Group type: COMPARATOR
Intervention: Management as usual
Number of subjects: 684
Study: 33931067

Group type: EXPERIMENTAL
Intervention: ACL repair using cortical button fixation and additional suture augmentation
Number of subjects: 74

Group type: COMPARATOR
Intervention: ACL reconstruction using an all‐inside autologous hamstring graft technique
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: ACL repair
Number of subjects: 74
Study: 34070161

Group type: EXPERIMENTAL
Intervention: Inquiry Based Stress Reduction (IBSR)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control
Number of subjects: 56
Study: 33242443

Group type: EXPERIMENTAL
Intervention: VTD (bortezomib, thalidomide, and dexamethasone)
Number of subjects: 480

Group type: COMPARATOR
Intervention: TD (thalidomide and dexamethasone)
Number of subjects: 480
Study: 35451359

Group type: EXPERIMENTAL
Intervention: Liver meat balls (LMB) supplement 3 times a week for 90 days
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group with no supplement
Number of subjects: 60
Study: 34748565

Group type: EXPERIMENTAL
Intervention: zoledronate (5mg)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: methylprednisolone (1gm)
Number of subjects: 43

Group type: COMPARATOR
Intervention: placebo (100ml normal saline)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 43
Study: 33919205

Group type: COMPARATOR
Intervention: Kinesiology taping (KT) with paper-off tension
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Kinesiology taping (KT) with 50% tension
Number of subjects: 12
Study: 32359057

Group type: EXPERIMENTAL
Intervention: Alcohol labels with national drinking guidelines, a cancer warning, and standard drink information applied to alcohol containers.
Number of subjects: 2049
Study: 35302300

Group type: EXPERIMENTAL
Intervention: Palonosetron
Number of subjects: 200

Group type: COMPARATOR
Intervention: Granisetron
Number of subjects: 200
Study: 32764474

Group type: EXPERIMENTAL
Intervention: VERTICAL with online teacher training
Number of subjects: 1639

Group type: EXPERIMENTAL
Intervention: VERTICAL with additional face-to-face teacher training
Number of subjects: 1639

Group type: COMPARATOR
Intervention: Control
Number of subjects: 1639

Group type: EXPERIMENTAL
Intervention: VERTICAL
Number of subjects: 1639
Study: 36446724

Group type: EXPERIMENTAL
Intervention: KangDuo surgical robot (KD‐SR)
Number of subjects: 100

Group type: COMPARATOR
Intervention: da Vinci Si Surgical System (DV‐SS‐Si)
Number of subjects: 100
Study: 33540298

Group type: EXPERIMENTAL
Intervention: Acupressure applied for a total of 12 minutes (3 minutes at each of the ST25, CV12, TH6, and HT7 acupuncture points) at 0, 4, and 8 hours postoperatively
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Acupressure
Number of subjects: 0
Study: 35717050

Group type: EXPERIMENTAL
Intervention: Intensity modulated and image guided radiation therapy (RT) with a dose of 50.4 Gy to primary PTV and 42 Gy to lymph node PTV, delivered over 28 fractions, with chemotherapy.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Use of vaginal dilators during RT to maximize genitalia sparing.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Customized immobilization device and daily image guided RT.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Simultaneous integrated boost technique with a 10‐mm margin on the gross tumor plus anal complex for primary clinical target volume.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 7‐mm expansion on blood vessels for elective lymph node clinical target volume.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 5‐ to 10‐mm planning target volume (PTV) margin based on institutional setup and patient‐specific factors.
Number of subjects: 0
Study: 34979824

Group type: EXPERIMENTAL
Intervention: Regression Point Displacement (RPD) design
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control groups from the RCTs
Number of subjects: 0
Study: 36097638

Group type: EXPERIMENTAL
Intervention: Rad-score
Number of subjects: 179

Group type: EXPERIMENTAL
Intervention: Nomogram
Number of subjects: 179

Group type: EXPERIMENTAL
Intervention: Positive lymph nodes
Number of subjects: 179

Group type: EXPERIMENTAL
Intervention: Cancer antigen-125
Number of subjects: 179
Study: 33888981

Group type: EXPERIMENTAL
Intervention: Mobile application (app) group
Number of subjects: 77

Group type: COMPARATOR
Intervention: Booklet group
Number of subjects: 77
Study: 32711555

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 196

Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 196
Study: 34407023

Group type: EXPERIMENTAL
Intervention: Online Mindfulness-Based Stress Reduction (MBSR) program for 7 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Comparison between intervention and control groups
Number of subjects: 0
Study: 32804885

Group type: EXPERIMENTAL
Intervention: Fusion to the touched vertebra (TV)
Number of subjects: 299

Group type: COMPARATOR
Intervention: Fusion cephalad to the TV
Number of subjects: 299

Group type: COMPARATOR
Intervention: Fusion caudad to the TV
Number of subjects: 299

Group type: COMPARATOR
Intervention: Fusion with lumbar modifier 'A'
Number of subjects: 299

Group type: COMPARATOR
Intervention: Fusion with lumbar modifiers 'B' and 'C'
Number of subjects: 299
Study: 35439906

Group type: EXPERIMENTAL
Intervention: Spinal anesthesia
Number of subjects: 117

Group type: COMPARATOR
Intervention: General anesthesia
Number of subjects: 117
Study: 34104089

Group type: EXPERIMENTAL
Intervention: Dexamethasone treatment
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (non-BPD infants)
Number of subjects: 30
Study: 32920824

Group type: COMPARATOR
Intervention: Topical corticosteroid (TCS)
Number of subjects: 517

Group type: COMPARATOR
Intervention: Handheld narrowband ultraviolet B (NB-UVB)
Number of subjects: 517

Group type: COMPARATOR
Intervention: Combination of topical corticosteroid (TCS) and NB-UVB
Number of subjects: 517
Study: 33347643

Group type: EXPERIMENTAL
Intervention: Local optimization algorithm for Kohn-Sham equations
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Local optimization algorithm with randomization of initial approximation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard self-consistent field (SCF) approach accelerated by direct inversion of the iterative subspace (DIIS)
Number of subjects: 0
Study: 35017127

Group type: EXPERIMENTAL
Intervention: Active tDCS targeting left dorsolateral prefrontal cortex (DLPFC)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Active tDCS targeting lateral temporoparietal area (LTA)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Active DLPFC-tDCS
Number of subjects: 64

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 64

Group type: COMPARATOR
Intervention: Rest (no stimulation)
Number of subjects: 64
Study: 34741843

Group type: EXPERIMENTAL
Intervention: Lateral episiotomy
Number of subjects: 19

Group type: COMPARATOR
Intervention: No episiotomy
Number of subjects: 19